Changes in cytosolic calcium are crucial for numerous processes including neuronal plasticity. This study investigates the regulation of cytosolic calcium by corticotropin-releasing factor (CRF) in midbrain dopamine neurons. The results demonstrate that CRF stimulates the release of intracellular calcium from stores through activation of adenylyl cyclase and PKA. Imaging and photolysis experiments showed that the calcium originated from dendrites and required both functional IP3 and ryanodine receptor channels. The elevation in cytosolic calcium potentiated calcium-sensitive potassium channels (sK) activated by action potentials and metabotropic Gq-coupled receptors for glutamate and acetylcholine. This increase in cytosolic calcium activated by postsynaptic Gs-coupled CRF receptors may represent a fundamental mechanism by which stress peptides and hormones can shape Gqcoupled receptor-mediated regulation of neuronal excitability and synaptic plasticity in dopamine neurons.
INTRODUCTION
In both in neurons and nonneuronal cells, changes in the concentrations of cytosolic (free) calcium regulate diverse processes including hormone secretion (Verkhratsky, 2005) , cytoskeletal rearrangement (Spira et al., 2001) , gene expression (West et al., 2001) , receptor trafficking (Ziff, 2007) , and neuronal plasticity (Ghosh and Greenberg, 1995) . Calcium enters the cytosol from two spatially distinct sources: intracellular stores and the extracellular space (Bootman et al., 2000) . Intracellular stores release calcium through channels located on the endoplasmic reticulum membrane such as the inositol triphosphate (IP3) receptor and the ryanodine receptor (Choi et al., 2006; Foskett et al., 2007) . IP3 receptors are recruited following activation of G q -protein coupled receptors and phospholipase C (PLC). Calcium release from IP3 receptors activates ryanodine receptor channels through calcium-induced calcium-release (Augustine et al., 2003) . Calcium entry from the extracellular space occurs through voltage-gated calcium channels that are activated upon depolarization. Increases in cytosolic calcium originating from both sources can activate intrinsic conductances, including small conductance calcium-activated potassium (sK) channels that are involved in synaptic integration and spike frequency adaptation (Bean, 2007; Bond et al., 1999; Womack et al., 2004) .
Mesocorticolimbic dopamine neurons, which originate from the ventral tegmental area and substantia nigra, encode signals important for movement and reinforcing behaviors such as drug abuse (Bjorklund and Dunnett, 2007; Grace et al., 2007; Wise, 2004) . Recent studies implicate corticotropin-releasing factor (CRF) in many central actions of drugs of abuse (Sarnyai et al., 2001) . CRF is a 41 amino acid peptide that mediates behavioral responses to stress through coordinated actions at two Gscoupled protein receptors (CRF-1 and CRF-2) (Chen et al., 1993; Stenzel et al., 1995) . CRF functions as a hormone within the hypothalamic pituitary axis (Hauger et al., 2006) , but is also synthesized and released in areas outside the hypothalamus (Orozco-Cabal et al., 2006; Swanson et al., 1983) . In nonneuronal cells, CRF and many other hormones increase cytosolic calcium through protein kinase A (PKA)-and PKC-dependent actions at internal stores and voltage gated calcium channels on the plasma membrane (Dermitzaki et al., 2004; Petersen et al., 1994) .
CRF receptors are present on midbrain dopamine neurons, but their impact on neuronal excitability remains poorly understood (Van Pett et al., 2000) . For instance, blockade of CRF receptors generates either no effect or decreases cocaineinduced dopamine release from terminals in the accumbens (Lodge and Grace, 2005; Lu et al., 2003) . However, CRF may stimulate the release of dopamine in other brain regions and increases DA neuron firing (Korotkova et al., 2006; Lavicky and Dunn, 1993) . Known actions of CRF on dopamine neurons involve the CRF-binding protein, PKC, and voltage gated calcium channels (Kim et al., 2007; Ungless et al., 2003) . A CRF-mediated increase in concentrations of cytosolic calcium in dopamine neurons has not been reported. However, the release of calcium from intracellular stores in dopamine cells activates an sK conductance following synaptic activation of metabotropic glutamate receptors (mGluRs) (Fiorillo and Williams, 1998; Morikawa et al., 2003) , alpha-1-adrenergic receptors , and muscarinic receptors (Fiorillo and Williams, 2000) . Moreover, calcium entry during action potentials results in an increase in an sK-dependent conductance (Cui et al., 2007; Wolfart et al., 2001; Wolfart and Roeper, 2002) . Such observations raise the possibility that in dopamine neurons, CRF could regulate sK-dependent currents by influencing the calcium associated with intracellular stores, calcium entry through voltage dependent channels, or both.
This study investigates the regulation of cytosolic calcium concentrations by CRF receptors in dopamine neurons. The results demonstrate that CRF stimulates the release of intracellular calcium from stores through activation of adenylyl cyclase and PKA. This release of calcium is sufficient to potentiate the sK channel inhibition mediated by G q -coupled receptors. The increase in calcium release from intracellular stores mediated by G s -activation may represent a fundamental mechanism by which stress peptides in particular and various hormones in general can shape the neuronal excitability and synaptic plasticity of dopamine neurons.
RESULTS

CRF Increases the Current Induced by mGluRs
The synaptic activation of mGluRs results in an outward current (IPSC) that is mediated by an increase in calcium-sensitive potassium conductance. Superfusion of CRF (300 nM) caused a significant increase in the amplitude of the inhibitory postsynaptic current (IPSC) mediated by the mGluR (230% ± 21% of control, n = 8; Figures 1A and 1B; p < 0.05). Likewise, CRF almost doubled the amplitude of the current induced by iontophoretic application of aspartate (182% ± 22% of control, n = 6; Figure 1B ; p < 0.05). In each experiment, the stimulus was adjusted such that the amplitude of the IPSC or outward current was less than 30% of the maximum such that the CRF-induced increase in current did not saturate the potassium conductance. The increase in both the IPSC and the current induced by aspartate peaked at $6 min following the onset of the CRF treatment and occurred without alteration in the holding current (control, À31 ± 3.8 pA; CRF, À34 ± 4 pA, n = 12; p > 0.05). At the end of the experiment apamin (100 nM) was used to block both currents. A second agonist specific for CRF-2 receptors, urocortin-III (UCN-III, 300 nM), produced a similar augmentation of both the IPSC (223% ± 18% of control, n = 6; p < 0.05) and aspartate induced current (189% ± 15% of control, n = 5; p < 0.05; Figure 1) . Application of UCN-III alone did not alter the holding current (control, À63 ± 10 pA; UCN-III, À70 ± 11 pA, n = 6; p > 0.05).
Concentration Dependence of CRF
The concentration dependence of CRF was evaluated over a range of 1-300 nM. In this experiment, the current induced by iontophoretic application of aspartate was used to avoid any potential presynaptic effects of CRF. At higher concentrations, the CRF-potentiation peaked within 6-8 min (300 nM CRF, 200% ± 39% at 6 min, n = 8; 100 nM CRF, 202% ± 18% at 8 min, n = 5; in all instances p < 0.05 versus baseline; Figure 2A) . Thereafter, the current declined despite the continued presence of CRF. The attenuation of the aspartate-induced current resembled the heterologous desensitization of sK current reported previously . Lower concentrations of CRF (1-30 nM) generated an increase of the aspartate-induced current that developed over a prolonged period and failed to plateau even after 20 min (Figure 2A ; 30 nM, 200% ± 44% at 20 min, n = 6; 3 nM, 182% ± 25% at 20 min, n = 6; 1 nM, 162% ± 12% at 20 min, n = 5; in all instances p < 0.05 versus baseline). In all subsequent experiments CRF (300 nM) was applied for 6-8 min.
CRF Activates CRF-R2
To determine which receptor subtype(s) modulate mGluR responses, CRF was tested in the presence of antagonists for CRF-R1 (antalarmin) or CRF-R2 (antisauvagine-30). Antalarmin (1 mM; incubation > 20 min) did not reduce the CRF potentiation (CRF, 182% ± 22%, n = 6; CRF + antalarmin, 215 ± 65 pA, n = 6; p > 0.05; Figure 2B ). In contrast, inclusion of antisauvagine-30 (1 mM; incubation > 10 min) completely blocked CRF-evoked increases in the current induced by iontophoretic application of aspartate (CRF, 200% ± 39%, n = 8; Figure 2A ; CRF + antisauvagine-30, 106% ± 15%, n = 6; Figure 2B ; p < 0.05; Jahn et al., 2004) . Antisauvagine-30 alone did not alter aspartateinduced currents or disrupt the facilitation induced by NS309 (10 mM), a stabilizer of the sK channel (antisauvagine-30, 100% ± 7%, n = 6; antisauvagine-30 + NS309, 217% ± 26%, n = 6; Figure 2B; p < 0.05). Neither antisauvagine-30 nor antalarmin altered the holding current (control, À58 ± 14 pA; antisauvagine-30, À50 ± 11 pA, n = 6, p > 0.5; control, À63 ± 11 pA; antalarmin, À50 ± 18 pA, n = 6, p > 0.5). These results suggest that the CRF-R2 subtype induced the modulation of mGluR-dependent current.
Interactions between CRF, CRF-R2, and the CRF-Binding Protein In addition to CRF receptors, CRF binds to the CRF-binding protein, which regulates the actions of CRF by buffering the amount of free CRF in the extracellular compartment. Slices were superfused with CRF6-33 (1 mM), a competitive inhibitor of the CRF-binding protein, resulting in an increase in the aspartate induced current (baseline, 99% ± 2%, n = 6; CRF6-33, 157% ± 23%, n = 6; Figure 1C ; p < 0.05). The potentiation induced by CRF6-33 was blocked after preincubation of the slice with antisauvagine-30 (1 mM; CRF6-33, 157% ± 23% n = 6; CRF6-33 + antisauvagine-30, 98% ± 5%, n = 5; Figure 2C ; p < 0.05), but not after incubation with antalarmin (1 mM, CRF6-33, 157% ± 23% n = 6; CRF6-33 + antalarmin, 167% ± 11%, n = 5; p > 0.05; not shown). These results suggest that CRF6-33 may displace/ release endogenous CRF into the extracellular space, resulting in the activation of CRF-R2 to increase the mGluR current.
Antisauvagine-30 blocked the actions of CRF and CRF6-33, but did not block the increase in sK current induced by forskolin (3 mM, CRF6-33 + antisauvagine-30, 107% ± 11%, n = 6; forskolin + CRF6-33 + antisauvagine-30, 176% ± 19%, n = 3; p < 0.05; not shown). Thus, blockade of the R2-CRF receptor did not prevent the increase induced by forskolin that acts on a process downstream of the receptor. were compared with the effect of forskolin, a potent activator of adenylyl cyclase. In this experiment, the current induced by iontophoretic application of aspartate was used because forskolin facilitates the presynaptic release of glutamate (Manzoni and Williams, 1999) . In the initial experiments, the actions of CRF (300 nM) on the mGluR-induced current were tested prior to the application of forskolin (Figures 3A and 3B) . CRF increased the sK current (to 177% ± 17% from baseline, 99% ± 2%, n = 14; Figure 3B ; p < 0.05) and because forskolin is a powerful activator of adenylyl cyclase it was capable of causing an additional potentiation of the current (forskolin, 3 mM, 265% ± 23% of baseline, n = 9; Figure 3B ; p < 0.05). Forskolin alone did not significantly alter the holding current (control, À23 ± 13 pA; forskolin, À38 ± 15 pA, n = 9, p > 0.05; not shown). Application of forskolin following washout of CRF resulted in a larger forskolin-induced increase in the sK current than forskolin application without prior CRF application (forskolin alone, 187% ± 16% of baseline, n = 8, Figure 3D , compared with 265% ± 23% of baseline following CRF, Figure 3B ; p < 0.05). When forskolin (3 mM) was applied for 12 min and immediately followed by an application of CRF (300 nM), CRF had no additional effect (CRF after forskolin, 198% ± 21%, n = 6, Figure 3D; CRF alone, 181% ± 22%, n = 6, Figure 3B ; p > 0.05). The observation that CRF had no additional effect following treatment with forskolin indicates that this action of CRF may be mediated by an activation of adenylyl cyclase. The lack of a further action of CRF was not limited by the potassium conductance, first because the initial current induced by aspartate was less than 30% of the maximum. Second, at the end of the experiment a longer application of aspartate further increased the outward current (322% ± 31% of baseline, n = 4, not shown).
During a 10-15 min application of forskolin, the increase in I sK peaked and thereafter declined ( Figures 3C and 6B ). This result was the same as that found with prolonged application of a high concentration of CRF (300 nM; Figure 2A ).
The role of protein kinase A (PKA) in the action of CRF and forskolin was tested using the pseudo-substrate blocker protein kinase inhibitor (PKI) (Scott et al., 1985 (Scott et al., , 1986 . The PKI was included in the intracellular solution and cells were equilibrated before CRF and forskolin were tested. After equilibration with PKI, neither CRF (4% ± 17% change, n = 8) nor forskolin (10% ± 15% change, n = 8) caused any significant change in the current induced by aspartate ( Figures 3A and 3B ). The holding current and the current induced by aspartate were not affected by the addition of PKI to the pipette solution. The potassium conductance could still be increased, because a stabilizer of sK-channels, NS309, tested at the end of these experiments caused an increase in the current (Pedarzani et al., 2005; Strobaek et al., 2004) . Application of NS309 (10 mM) increased the current (204% ± 18%, n = 5, p < 0.05 versus baseline) in the presence of PKI ( Figures 3A and 3B) . The inactive analog of forskolin 1,9-dideoxyforskolin (3 mM) had no effect on the aspartateinduced current (104% ± 4%, n = 5; baseline, 99% ± 4%, n = 5; Figure 3C ; p > 0.05). Likewise, when phorbol-ester-dybutyrate (PDBu) was used to activate protein kinase C (PKC), the current induced by aspartate was not changed (106% ± 7%, n = 5; baseline, 99% ± 4%, n = 5; Figure 3C ; p > 0.05). Thus, both CRF and forskolin enhanced the mGluR-mediated outward current by a PKA-dependent mechanism.
Activation of Adenylyl Cyclase Increased Calcium in Dendrites
In dopamine neurons, the outward current induced by activation of metabotropic glutamate receptors is dependent on the release of calcium from intracellular stores (Morikawa et al., 2003) . The increase in the current induced by CRF or forskolin could result from a number of different mechanisms including an increase in the release of calcium from intracellular stores or an increase in the sensitivity of the calcium-sensitive potassium channel for calcium.
These potential mechanisms were tested first by measuring the rise and fall in intracellular calcium induced by aspartate before and during application of forskolin (3 mM; Figures 4 and 5). Forskolin increased both the outward current induced by aspartate (control, 28.9 ± 3.6 pA, n = 12; forskolin, 71.6 ± 9.3 pA, n = 12; p < 0.001, Figure 5A ) and simultaneously increased the dendritic calcium transients (DG/R; control, 1.90 ± 0.36%, n = 12; forskolin, 3.32% ± 0.54%, n = 12; p < 0.05; Figure 5B ). The facilitation of calcium was dendritic in origin at or near the point where the initial rise in calcium was evoked.
These results suggest that the increase in sK conductance induced by forskolin results from an increased release of calcium. One possibility is that there is a PKA-dependent effect directly on the metabotropic glutamate receptor. The effect of forskolin was therefore tested on a second phosphatidylinositol (PI)-coupled receptor, i.e., the M1-muscarinic receptor. Activation of M1 receptors results in the release of calcium from intracellular stores and the activation of a calcium-dependent outward sK current (Fiorillo and Williams, 2000) . Iontophoresis of acetylcholine (ACh), in the presence of the nicotinic acetylcholine receptor antagonist, hexamethonium (200 mM), caused an outward current and a transient rise in calcium ( Figures 5C and 5D ). Forskolin increased the ACh-induced current (control, 24.6 ± 3.1 pA, n = 5; forskolin, 78.0 ± 6.9 pA, n = 5; p < 0.001) and the rise in intracellular calcium (DG/R control, 1.13% ± 0.29%, n = 5; forskolin, 2.58% ± 0.47%, n = 5; p < 0.05).
Next, the activation of PI-coupled receptors was bypassed, and an increase in intracellular calcium was evoked by depolarizing the cell to 0 mV for 50-200 ms. The resulting apaminsensitive outward current was measured upon repolarization to À60 mV (Cui et al., 2007; Wolfart et al., 2001) . Forskolin increased this outward current (control, 154 ± 28 pA, n = 4; forskolin, 306 ± 51 pA, n = 4, p < 0.05; not shown) and the calcium transients measured with Fluo5F (40 mM, DG/R, control, 0.47% ± 0.22%, n = 4; forskolin, 1.8% ± 0.12%, n = 4; p < 0.05; not shown).
Thus, forskolin had the same action to increase the sK current and intracellular calcium transient following stimulation of metabotropic glutamate and M1-muscarinic receptors as well as the outward current induced by calcium entry through voltagedependent calcium channels. It is therefore likely that the target of PKA-phosphorylation is not Gq-coupled receptors.
The Potentiation Does Not Require Extracellular Calcium
The results suggest that activation of adenylyl cyclase increases the calcium transient to facilitate the activation of the apaminsensitive potassium current. To determine the role of extracellular calcium, the ability of forskolin and CRF to increase the aspartate-induced current was examined in calcium-free solution (with EGTA, 500 mM, Figure 6 ). The aspartate-induced current was not significantly reduced during treatment with the calcium-free solution for 10 min (baseline, 100% ± 5%, n = 10; calcium-free, 83% ± 8%, range 66%-107%, n = 10; p > 0.05). Both CRF and forskolin caused an increase in the current in calcium-free solution (forskolin, 244% ± 10%, n = 5, p < 0.05 versus baseline; p < 0.05 versus calcium-free; CRF, 186% ± 11%, n = 5, p < 0.05 versus baseline; p < 0.05 versus calcium-free; Figure 6B ). The result suggests that the PKA-mediated facilitation of I sK was not dependent on extracellular calcium.
Dependent on Intracellular Calcium
Although the forskolin-induced increase in outward current was accompanied by an increase in intracellular calcium, it was possible that the sensitivity of the potassium channel to calcium was also increased. A transient increase in Intracellular calcium was induced using photolytic release of calcium from caged-calcium (NP-EGTA). The intracellular solution contained NP-EGTA (1.5 mM), and calcium-induced outward currents were evoked by photolysis every 2 min.
The outward current induced by the uncaging of calcium was stable over time and in all instances was eliminated by apamin (100 nM, not shown). Both CRF and forskolin ( Figures 7A and  7B ) increased the outward current induced by calcium photolysis (CRF, 146% ± 29%, n = 5; forskolin, 155% ± 16%, n = 6; Figures 7 A and 7B; p < 0.05 agonist versus baseline). Application of NS309 (10 mM) to stabilize the sK channel produced a further significant increase in the outward current (CRF + NS309, 197% ± 51%, n = 5; forskolin + NS309, 215% ± 44%, n = 5; Figures 7A and 7B; p < 0.05). These results do not rule out a direct action of PKA on the potassium channel.
The involvement of intracellular calcium stores in calcium-dependent calcium release was examined by depleting intracellular stores with cyclopiazonic acid (CPA, 10 mM). Treatment with CPA alone produced a significant decrease in the outward current induced by the photolysis of caged calcium (Figures 7C and 7D ; to 72% ± 10% of baseline, n = 10; p < 0.05). This observation indicated that the photolytic release of calcium resulted in a further release of calcium from intracellular stores. Once CPA had depleted internal stores, neither CRF nor forskolin had an effect ( Figures 7C  and 7D ). After treatment with CPA, NS309 caused a significant increase in the sK current, indicating that CPA did not directly affect the potassium conductance (forskolin, 63% ± 23%, n = 5; forskolin + NS309, 207% ± 41%, n = 5; p < 0.05; CRF, 41% ± 25%, n = 5; CRF + NS309, 169% ± 29%, n = 5, p < 0.05; Figure 7D ). Thus, functional intracellular calcium stores are essential for PKA-dependent augmentation of the calcium sensitive potassium channels.
Two Pathways
The outward current induced by activation of metabotropic glutamate receptors was mediated by two pathways; one is sensitive to heparin (IP3 receptor-dependent) and the second is sensitive to 8-amino-cADP-ribose (cADP/ryanodine receptordependent) (Morikawa et al., 2003) . To determine if both pathways were sensitive to forskolin, two experiments were preformed. The first experiment was to block IP3 receptors with intracellular heparin (1 mg/ml) and test the effect of forskolin on the outward current induced by aspartate. The second experiment was to block cADP-ribose receptors with intracellular 8-amino-cADP-ribose (50 mM).
Under control conditions, forskolin potentiated the aspartate-induced current (control, 31 ± 10 pA; forskolin, 137 ± 10 pA, n = 5 cells/group, p < 0.001; Figures 8A and 8B) . Although the inclusion of heparin or 8-NH2-cADP-ribose reduced the effectiveness of forskolin by about half, forskolin still caused a significant augmentation (heparin alone, 52 ± 9 pA; heparin + forskolin, 81 ± 14 pA; n = 6, p < 0.05; 8-NH 2 -cADP-ribose alone, 49 ± 4 pA; 8-NH 2 -cADPribose + forskolin, 83 ± 10 pA; n = 5, p < 0.01; Figures 8A and 8B) . Thus, forskolin enhanced both ryanodine and IP3 receptor-mediated release of calcium from intracellular stores to increase the activation of sK. Further evidence for the redundancy of the two pathways is illustrated in Figure S1 , available online. Together these results imply that the CRF Gs-linked pathway amplifies perhaps all Gq-receptor-dependent signaling via PKA phosphorylation, leading to increased release of calcium from intracellular stores.
DISCUSSION
This study demonstrates that in dopamine neurons, the stress hormone CRF facilitates the release of calcium from intracellular stores by a PKA-dependent mechanism (Figure 9 ). Thus, CRF would augment any mechanism that caused calcium release from intracellular stores. Given the importance of calcium as a second messenger, the potential actions of CRF are expected to be manifold.
The measure used in this study was the activation of a calcium-sensitive potassium conductance that directly regulates the excitability of dopamine neurons. The local increase in calcium was sufficient to augment the inhibition induced by both synaptic (mGluR) and intrinsic (after-hyperpolarization) mechanisms. Dopamine neuron excitability is regulated by calciumdependent mechanisms (both intrinsic and synaptic), so that the synergy between Gs-and Gq-coupled systems may represent a fundamental strategy for shaping neuronal excitability.
CRF Receptors and the CRF-Binding Protein
The increase in sK current induced by CRF was concentration dependent, significant at a low concentration (1 nM) and dependent on the activation of PKA. The pharmacological experiments using selective agonists and antagonists indicate that this action is mediated by a CRF-R2 subtype receptor. Application of CRF6-33 resulted in a CRF-R2 receptor-dependent facilitation of the potassium current, suggesting the presence of endogenous CRF in these brain slices. Thus, the CRF-binding protein may hold a reservoir of CRF. Regulation of the interaction between CRF and the CRF-binding protein may represent a mechanism by which CRF can be released to activate receptors on dopamine neurons. This observation differs from the PKC-dependent facilitation of NMDA currents in dopamine neurons that was blocked by CRF6-33 (Ungless et al., 2003) .
Activation of Adenylyl Cyclase Increased Release of Calcium from Stores
Four different experiments indicated that activation of adenylyl cyclase potentiates sK currents through increases in cytosolic calcium, rather than enhancing influx of extracellular calcium. First, in extracellular solution containing no added calcium (and inclusion of EGTA), CRF facilitated the sK current evoked by activation of metabotropic glutamate receptors. Second, calcium-imaging experiments measured local increases in dendritic calcium, time-locked to facilitation of the sK current. Third, depletion of intracellular calcium stores with CPA decreased photolysis-evoked currents and eliminated the CRF-and forskolin-evoked facilitation of sK current. Fourth, blockade of IP3 receptors with heparin or cADP-ribose receptors with 8-aminocADP-ribose attenuated the forskolin-evoked increases in the sK current.
CRF-evoked increases in cytosolic calcium may represent an elementary action of hormones in general, with the underlying mechanism dictated by the specific neuron or cell studied. For instance, in other neuronal or nonneuronal systems, CRF also (B) Summarized results showing the increase in the current evoked by both forskolin (3 mM, n = 6) and CRF (300 nM, n = 5). Subsequent application of NS309 (10 mM) caused a further significant increase in the current following CRF or forskolin (p < 0.05).
(C) Raw current traces showing that the current resulting from photolysis of caged calcium is dramatically decreased after depletion of intracellular calcium stores with cyclopiazonic acid (CPA 10 mM). After CPA, CRF (300 nM) does not increase the outward current. (D) Summarized data showing the decline in current induced by CPA and the blockade of the potentiation induced by forskolin (3 mM, n = 5) and CRF (300 nM, n = 5). The current was still augmented by NS309 (10 mM). increases intracellular calcium (Dermitzaki et al., 2004; Kageyama et al., 2006; Tao et al., 2006; Yamamori et al., 2004) . The increase in intracellular calcium can result from the release of calcium from internal stores and/or the activation of voltage dependent calcium channels (Duridanova et al., 1999; Haug and Storm, 2000; Huang et al., 2003; Kanno et al., 1999; Petkova-Kirova et al., 2000) . Moreover, the actual release of calcium may be regulated by multiple kinases (Fazal et al., 1998; Guerineau et al., 1991; Kim et al., 2007; Kuryshev et al., 1996; Lee and Tse, 1997; Luini et al., 1985; Spada et al., 1990; Takuma et al., 1994) . Similar results are reported with CCK, serotonin, vasoactive intestinal peptide, neurotensin, vasopressin, and norepinephrine (Belmeguenai et al., 2003; Gaisano et al., 1994; Kudoh et al., 2003; Petersen et al., 1994; Tse and Lee, 1998) . The spatial and temporal properties of the increases in intracellular calcium, however, vary considerably with each hormone. The same hormone can generate global, long-lasting changes in one region of the cell and yet discrete, short-lasting calcium spikes in another region (Petersen et al., 1994) . Thus, although our results highlight the actions of CRF and PKA on internal stores at or near dendrites, we do not exclude other possible actions of CRF in dopamine neurons.
PKA Regulates Increases in Cytosolic Calcium
Activation of PKC with the phorbol ester, PDBu, did not potentiate the sK current. In contrast, the inhibition of PKA (with PKI) blocked the action of CRF. These results in brain slices are consistent with other reports using expression systems to investigate CRF-R2, urocortin-III, and cAMP (Hsu and Hsueh, 2001; Jahn et al., 2004; Lewis et al., 2001) . The activation of PKA could augment calcium release through several actions. First, PKA-dependent phosphorylation is known to increase both the size and the rate of calcium uptake into the calcium pool (Bruce et al., 2003; Bugrim, 1999; Furuichi et al., 1994) . Second, PKA can directly increase the open probability of ryanodine receptors, which like the IP3 contains a consensus sequences for PKA (Marx et al., 2000; Mignery et al., 1990; Sudhof et al., 1991) . Third, PKA can phosphorylate signaling scaffolds and thereby position Gs-signaling components in close proximity to clusters of IP3 and ryanodine receptors (Augustine et al., 2003; Berridge et al., 2003; Tu et al., 1998) . One relevant example is the interaction between signaling scaffold A-kinase anchoring proteins (AKAPs) and the hormone vasoactive intestinal peptide (VIP) (Beene and Scott, 2007; Smith et al., 2006) . Like CRF, VIP activates Gs, adenylyl cyclase, cAMP, and PKA (Hagen et al., 2006) . The application of either VIP or a cAMP analog increases the release of calcium from IP3 receptors. Blockade of ryanodine receptors does not attenuate release from IP3 receptors. However, either disruption of AKAPs or the blockade of ryanodine receptors eliminates the potentiation by both VIP and the cAMP analog (Hagen et al., 2006) . It is conceivable that similar actions could be relevant to CRF.
Implications for Dopamine Neuron Excitability
In many brain regions, recruitment of sK channels regulates synaptic integration and spike frequency adaptation (Bond et al., 1999; Womack et al., 2004) . The importance of calcium in this process can be inferred from studies in the cerebellum where deletion of IP3 and ryanodine receptors dramatically disrupts LTD and impairs synaptic plasticity (Balschun et al., 1999; Inoue et al., 1998; Taufiq et al., 2005) . Such changes predominantly alter weaker forms of plasticity without affecting neuronal morphology, basal synaptic transmission, or presynaptic function (Balschun et al., 1999) .
In dopamine neurons, opening of the sK channel is precisely controlled by increases in intracellular calcium arising from two sources (Bean, 2007; Stocker, 2004) . First, synaptic activation of metabotropic glutamate receptors activates PLC to release calcium from internal stores that activate sK (Fiorillo and Williams, 1998; Morikawa et al., 2003) . Second, action potentials activate voltage-gated calcium channels to initiate calcium influx across the plasma membrane, thus stabilize spiking precision during increased action-potential firing (Wolfart et al., 2001; Wolfart and Roeper, 2002) . Coordination between these systems exists, as the calcium released by a burst of action potentials is potentiated by the increases in IP3 receptor tone initiated by metabotropic glutamate receptors (Cui et al., 2007) . Unlike most neurons in the brain, the axon of dopamine neurons originates from a dendrite (Grace and Onn, 1989; Hausser et al., 1995) . Consequently, the generation of action potentials in dopamine cells is dendritic in origin followed by back-propagation into soma (Gentet and Williams, 2007) . This arrangement renders the dendrite that posses the axon disproportionately important for generation of action potentials (Gentet and Williams, 2007) . Potentiation of the sK current by CRF in that dendrite would be predicted to have a strong influence on excitability (Gentet and Williams, 2007) . Thus, CRF could serve as an important coincidence detector to correlate activity inputs by integrating the calcium originating from action potentials with the release of The facilitation induced by forskolin (F in each case) was present but reduced in experiments where IP3 receptors were blocked by heparin or cADP-ribose receptors were blocked by 8-amino-cADP-ribose (8-Ribose). There was a significant increase induced by forskolin in each experiment (*p < 0.05), and the forskolin-induced increase after treatment with heparin and 8-NH 2 -cADP-ribose was significantly smaller from that in control (*p < 0.05 and **p < 0.01). Error bars indicate SEM.
calcium from intracellular stores induced by Gq-coupled receptors (Cui et al., 2007; Nakamura et al., 1999) .
EXPERIMENTAL PROCEDURES Slices and Solutions
Slices containing midbrain DA neurons from male rats (P30-75) were prepared as described previously (Morikawa et al., 2003) . Briefly, horizontal midbrain slices (220 mm) were cut in ice-cold saline containing 126 mM NaCl, 2.5 mM KCl, 1.2 mM MgCl 2 , 2.4 mM CaCl 2 , 1.4 mM NaH 2 PO 4 , 25 mM NaHCO 3 , 11 mM D-glucose, 0.4 mM ascorbate, and 0.01 mM MK801 using a vibratome (Leica). Slices were stored in 35 C oxygenated (95% O 2 %-5% CO 2 ) saline containing MK-801 (10 mM) for 30 min before recording. Electrophysiological recordings were performed at 35 C. The perfusion rate of oxygenated saline (95% O 2 %-5% CO 2 ) was 2 ml/min. Neurons were visualized with either an Olympus BX51WI (Olympus America) or Zeiss Axioskop microscope. Microscopes were equipped with gradient contrast infrared optics (Dodt et al., 2002) .
Whole-Cell Recordings
Whole-cell recordings were made using Axopatch 1D or Axopatch 200A amplifiers (Axon Instruments). Neurons were voltage clamped at À60 mV using 1.5-2.0 MU pipettes. Pipette internal solution contained 115 mM K-methylsulfate, 20 mM NaCl, 1.5 mM MgCl 2 , 5 mM HEPES, 2 mM ATP, and 0.3 mM GTP (pH 7.3; 265-270 mOsm). Unless noted otherwise, internal solution contained 0.1 mM EGTA. Series resistance (3-15 MU) was compensated at 80%. DA neurons resided <150 mm from the lateral or medial side of the terminal nucleus of the accessory optic tract (MT). This is a region rich in dopamine cell bodies (Ford et al., 2006; Wolfart et al., 2001) . Recordings from neurons in this region displayed pacemaker firing (1-2 Hz), broad action potentials (R1.2 ms), and large H currents (>300 pA at À120 mV) (Fiorillo and Williams, 1998; Ford et al., 2006; Wolfart et al., 2001 ). The hyperpolarizing mGluR-mediated current carried by the sK channel is observed only in dopamine neurons in midbrain slices (Marino et al., 2001) . Though there have been reports of difficulties in identifying dopamine neurons, the combination of the area in which the recordings were made coupled with the criteria used to identify the electrophysiological characteristic of dopamine cells indicates that the results are based on recordings from dopamine cells. Recordings were collected using AxoGraph X (AxoGraph Scientific) and filtered at 1-2 kHz, digitized at 2-5 kHz. A monopolar saline-filled glass electrode (3-6 MU) was used to evoke synaptic release. A train of stimuli (2-5 stimuli, 0.2 ms duration, 40 Hz, once per minute) was used to evoke IPSCs mediated by the activation of mGluRs (Fiorillo and Williams, 1998) . The mGluR IPSC was isolated pharmacologically with picrotoxin (100 mM), 6,7-dinitroquinoxaline-2,3-dione (DNQX, 10 mM), CGP55845 (200 nM), sulpiride (1 mM), and MK-801 (10 mM). Iontophoretic application of aspartate (200 nA, 5-75 ms) was used to activate postsynaptic mGluRs. The amplitude of all sK currents were adjusted to approximately 20%-30% of maximum.
Imaging Experiments
Simultaneous calcium imaging and whole cell voltage-clamp recording was preformed using an electrophysiological setup equipped with a purpose-built two-photon microscope controlled via Scan Image software (Pologruto et al., 2003) . Neurons were filled for 20-25 min with an internal (K-methylsulfate) solution containing Alexa Fluor 594 (5 mM) and either Fluo4, Fluo5F, or OregonGreenBAPTA488-5N (40 mM). The EGTA in the internal solution was omitted in these experiments. Alexa Fluor 594 (5 mM), which was not sensitive to calcium, was used to normalize the changes in fluorescence of the calcium-sensitive dye (change in green fluorescence/red fluorescence, DG/R [Sabatini et al., 2002] ). The red fluorescence was also used to visualize the cellular morphology and to identify dendrites $10-45 mm distal to soma where line scans were taken to measure aspartate induced change in fluorescence. By limiting the amplitude of the aspartate induced current to 10%-20% of maximum, the problem of saturating the calcium indicator was reduced. The fluorescence of dendritic process was measured over a period of 4 s using a line scan. Offline data analysis was performed using Image-J (NIH) and AxoGraph X (AxoGraph Scientific). The values of DG/R represent averages of 3-5 line scans surrounding the maximum changes induced by each drug. Summary data are reported as mean ± SEM. Significance was defined as p < 0.05, using the two-tailed Student's t test.
Photolysis Experiments
Photolysis experiments were conducted using UV pulses supplied by a shuttered mercury lamp (100 W, Olympus America) and NP-EGTA (Ellis-Davies et al., 1996; Ellis-Davies and Kaplan, 1994; Zimmermann et al., 1995) . Immediately prior to use, NP-EGTA (1.5 mM) was mixed with CaCl 2 (1.2 mM; Neher and Zucker, 1993) in a K-methylsulfate internal solution lacking EGTA. Solutions were stored at À70 C and discarded after 3 days. Neurons were loaded for $5-10 min prior to photolysis. The amplitude of the flash-evoked current increased proportionally with increasing shutter duration (12-200 ms). Baseline amplitudes were adjusted to $10%-20% of the maximum resulting from a long shutter opening duration (200-400 ms). The interval between two pulses was 2 min to allow re-equilibration of caged compound. Drugs DNQX, MK-801, CGP55845, CRF, cyclopiazonic acid (CPA), PKI (6-22) were obtained from Tocris Bioscience. Heparin and forskolin were purchased from Calbiochem. Alexa 594, Fluo5F, Fluo4FF, OGB488-5N, and NP-EGTA were purchased from Invitrogen. All other chemicals were obtained from Sigma-RBI.
Statistical Analysis
One-way ANOVA was used to determine effects of independent variables, followed when appropriate by Tukey's post hoc test. When only two groups were involved, comparisons were made with paired t test (within cell). Data are presented as mean ± SEM with n designating the number of cells obtained in each experimental group. In Figure 2A , lines were drawn to illustrate the overall time course of the action of CRF. All statistical analysis was preformed using Prism 4.03 (GraphPad Software Inc).
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